Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$17.1 - $23.34 $1.02 Million - $1.4 Million
-59,800 Closed
0 $0
Q3 2021

Sep 21, 2023

BUY
$19.68 - $22.53 $226,320 - $259,095
11,500 Added 23.81%
59,800 $1.18 Million
Q3 2021

Nov 15, 2021

BUY
$19.68 - $22.53 $226,320 - $259,095
11,500 Added 23.81%
59,800 $1.18 Million
Q2 2021

Sep 21, 2023

BUY
$19.97 - $24.43 $964,551 - $1.18 Million
48,300 New
48,300 $1.06 Million
Q2 2021

Aug 16, 2021

BUY
$19.97 - $24.43 $964,551 - $1.18 Million
48,300 New
48,300 $1.06 Million
Q4 2020

Feb 16, 2021

SELL
$16.78 - $27.3 $318,820 - $518,700
-19,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$12.46 - $19.98 $42,364 - $67,932
3,400 Added 21.79%
19,000 $331,000
Q2 2020

Aug 14, 2020

BUY
$11.0 - $18.26 $171,600 - $284,856
15,600 New
15,600 $262,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.29B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.